Target intelligence / Profile preview

G protein-coupled receptor 37-like 1 (GPR37L1)

Target
GPR37L1
Molecular classification
G protein-coupled receptor, Rhodopsin-like receptor (Class A/1), Receptor
01

Overview

G protein-coupled receptor 37-like 1 (GPR37L1) is an orphan G protein-coupled receptor highly expressed in glial cells within the central and peripheral nervous systems, especially in cerebellar astrocytes (Bergmann glia) and satellite glial cells. It plays a role in signal transduction by coupling to the G(s) protein and regulates important glial functions, including potassium channel activity and synaptic signaling. GPR37L1 has been implicated in the modulation of the sonic hedgehog (Shh) pathway during cerebellar development and is involved in neuroprotection, pain regulation, and cardiovascular homeostasis. The receptor can be activated by the lipid mediator maresin 1, which enhances neuroprotective signaling, and has been proposed to interact with prosaposin, though functional activity is debated. Genetic variants in GPR37L1 have been associated with susceptibility to chronic pain and epilepsy. Loss or dysfunction of GPR37L1, as seen in transgenic mice, leads to impaired neuropathic pain resolution and altered cerebellar development[1][2][3][4][5].

Other names
Endothelin B receptor-like protein 2ET(B)R-LP-2ETBR-LP-2ETBRLP2Prosaposin receptor GPR37L1G-protein coupled receptor 37-like 1Endothelin type b receptor-like protein 2
02

Mechanism of action

Activation by maresin 1 to regulate potassium influx via Kir4.1/Kir3.1; Constitutive activity through Gs signaling; Activation by prosaposin (uncertain and debated; studies report mixed findings on activity)

03

Biological functions

Signal transductionRegulation of potassium channel activityPositive regulation of MAPK cascadeRegulation of cerebellar development (Shh signaling modulation)NeuroprotectionInhibition of astrocyte glutamate transporter activityRegulation of blood pressureSynaptic signaling
04

Disease associations

Neurodegenerative diseaseNeuropathic painEpilepsyCardiovascular diseaseChronic painCerebellar medulloblastoma
05

Safety considerations

Potential for modulating seizure susceptibility and chronic pain risk via genetic variantsAltered expression might affect glial-neuronal signaling, which could have neurological consequences (based on animal studies)
06

Interacting drugs

Maresin 1 (endogenous ligand, specialized proresolving lipid mediator)
07

Biomarkers

GPR37L1 protein expression level (potential marker for neuropathic pain susceptibility)GPR37L1-E296K variant (genetic risk for chronic pain)

Beyond the preview

Go deeper on G protein-coupled receptor 37-like 1 (GPR37L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor 37-like 1 (GPR37L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call